Koyfin Home > Directory > Health Care > Ironwood Pharmaceuti > EV / EBITDA (ntm)

Ironwood Pharmaceuti EV / EBITDA (ntm) Chart (IRWD)

Ironwood Pharmaceuti annual/quarterly EV / EBITDA (ntm) from 2016 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Ironwood Pharmaceuti EV / EBITDA (ntm) for the quarter ending October 10, 2020 was 11.29 a -1.31% decrease of -0.15 year over year
  • Ironwood Pharmaceuti EV / EBITDA (ntm) for the last 12 months ending October 10, 2020 was 11.29 a -1.31% decrease of -0.15 year over year
  • Ironwood Pharmaceuti Annual EV / EBITDA (ntm) for 2020 was 11.29 a -0.94% decrease of -0.11 from 2019
  • Ironwood Pharmaceuti Annual EV / EBITDA (ntm) for 2020 was 11.40 a 0.28% increase of 0.03 from 2019
  • Ironwood Pharmaceuti Annual EV / EBITDA (ntm) for 2020 was 11.36 a -0.65% decrease of -0.07 from 2019
Other Valuation Metrics:
  • Ironwood Pharmaceuti Market Cap for the quarter ending March 03, 2018 was $2,328m a -20.51% decrease of -478m year over year
  • Ironwood Pharmaceuti Price / Book for the quarter ending March 03, 2018 was 235.73 a 84.11% increase of 198.27 year over year
  • Ironwood Pharmaceuti Enterprise Value for the quarter ending March 03, 2018 was $2,507m a -15.67% decrease of -393m year over year
View Chart On Koyfin

Quarterly IRWD EV / EBITDA (ntm) Data

10/202011.29
10/202011.40
10/202011.36
10/202011.44
10/202010.83
10/202010.81
10/202011.21
10/202011.58
10/202012.10
10/202011.32

Annual IRWD EV / EBITDA (ntm) Data

202011.29
202011.40
202011.36
202011.44
202010.83
202010.81
202011.21
202011.58
202012.10
202011.32